SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 27th, 2017 • Immucell Corp /De/ • In vitro & in vivo diagnostic substances • New York
Contract Type FiledJuly 27th, 2017 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of July 27, 2017, between ImmuCell Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).